Bio-Path Holdings Inc (BPTH)
0.9963
+0.02
(+1.66%)
USD |
NASDAQ |
Nov 04, 16:00
0.9886
-0.01
(-0.77%)
After-Hours: 20:00
Bio-Path Holdings Enterprise Value: -1.463M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -1.463M |
| November 01, 2024 | -1.505M |
| October 31, 2024 | -1.695M |
| October 30, 2024 | -1.503M |
| October 29, 2024 | -1.301M |
| October 28, 2024 | -1.250M |
| October 25, 2024 | -1.199M |
| October 24, 2024 | -1.275M |
| October 23, 2024 | -1.275M |
| October 22, 2024 | -1.148M |
| October 21, 2024 | -1.275M |
| October 18, 2024 | -1.224M |
| October 17, 2024 | -1.275M |
| October 16, 2024 | -1.045M |
| October 15, 2024 | -1.071M |
| October 14, 2024 | -1.122M |
| October 11, 2024 | -1.122M |
| October 10, 2024 | -1.096M |
| October 09, 2024 | -1.199M |
| October 08, 2024 | -0.9689M |
| October 07, 2024 | -1.833M |
| October 04, 2024 | -1.783M |
| October 03, 2024 | -1.71M |
| October 02, 2024 | -1.754M |
| October 01, 2024 | -1.760M |
| Date | Value |
|---|---|
| September 30, 2024 | -1.684M |
| September 27, 2024 | -1.639M |
| September 26, 2024 | -1.632M |
| September 25, 2024 | -1.661M |
| September 24, 2024 | -1.632M |
| September 23, 2024 | -1.786M |
| September 20, 2024 | -1.732M |
| September 19, 2024 | -1.554M |
| September 18, 2024 | -1.454M |
| September 17, 2024 | -1.331M |
| September 16, 2024 | -1.454M |
| September 13, 2024 | -1.403M |
| September 12, 2024 | -1.513M |
| September 11, 2024 | -1.530M |
| September 10, 2024 | -1.677M |
| September 09, 2024 | -1.480M |
| September 06, 2024 | -1.495M |
| September 05, 2024 | -1.528M |
| September 04, 2024 | -1.621M |
| September 03, 2024 | -1.477M |
| August 30, 2024 | -1.488M |
| August 29, 2024 | -1.534M |
| August 28, 2024 | -1.536M |
| August 27, 2024 | -1.122M |
| August 26, 2024 | -0.9944M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.092M
Minimum
Mar 16 2020
40.02M
Maximum
Feb 18 2021
5.612M
Average
4.251M
Median
Enterprise Value Benchmarks
| Aadi Bioscience Inc | -30.32M |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.869M |
| Total Expenses (Quarterly) | 3.038M |
| EPS Diluted (Quarterly) | -1.16 |
| Earnings Yield | -1.67K% |
| Normalized Earnings Yield | -40174.48 |